Format

Send to

Choose Destination
See comment in PubMed Commons below
Nanomedicine (Lond). 2014 Jan;9(1):35-43. doi: 10.2217/nnm.13.7. Epub 2013 Apr 23.

Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccine.

Author information

1
The University of Queensland (St Lucia), School of Chemistry & Molecular Biosciences, Brisbane, Queensland 4072, Australia.

Abstract

AIM:

To explore four-arm star poly(t-butyl)acrylate (P(t)BA)-peptide and linear P(t)BA-peptide conjugates as a vaccine-delivery system against Group A Streptococcus.

MATERIALS & METHODS:

P(t)BA nanoparticles bearing J14 peptide epitopes were prepared via alkyne-azide 1,3-dipolar cycloaddition 'click' reaction. The conjugated products were self-assembled into small or large nanoparticles. These nanoparticle vaccine candidates were evaluated in vivo and J14-specific antibody titers were assessed.

RESULTS & DISCUSSION:

Mice vaccinated with the nanoparticles were able to produce J14-specific IgG antibodies without the use of an external adjuvant after a single immunization. We have demonstrated for the first time that the immune responses against self-assembled P(t)BA nanoparticles are stronger for the smaller sized (~20 nm) nanoparticles compared with the larger (~500 nm) P(t)BA nanoparticles.

CONCLUSION:

PtBA analogs have the potential to be developed as potent carrier systems for single-dose synthetic vaccines.

PMID:
23611619
DOI:
10.2217/nnm.13.7
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center